The Monetary Authority of Singapore (MAS) and the People’s Bank of China (PBC) discussed initiatives to advance cooperation in green and transition finance between China and Singapore at the 2nd China ...
AstraZeneca Announces $1.5 Billion Investment in Manufacturing Facility in Singapore
AstraZeneca’s ambitious plan to construct a $1.5 billion manufacturing facility in Singapore heralds a new chapter in the company’s quest to bolster its global supply of cancer-fighting medications.
AstraZeneca to build $1.5bn ADCs facility in Singapore
Pharmaceutical giant AstraZeneca has announced plans to invest $1.5bn in a new antibody-drug conjugates (ADCs) manufacturing facility in Singapore.
AstraZeneca unveils plan for $1.5bn ADC plant in Singapore
AstraZeneca is backing up its considerable investment in antibody-drug conjugates (ADCs) for cancer with the construction of a $1.5 billion new facility in Singapore to manufacture them.
Singapore Market ends flat
At closing bell, the Straits Times Index (STI) index edged up 0.57 point, or 0.02% to 3,314.05 after trading between 3,306.32 and 3,318.24. Across the broader market, advancers outpaced decliners 333 ...
STI ends almost flat as market faces reality check
Market watchers said all eyes remain on China, and Asian markets are likely to take their cue from the global economic powerhouse. Mixed macroeconomic data from China shows that the country’s recovery ...
Pine Labs Awaits India Nod For Reverse Flip After Singapore Approval
Singapore-based Pine Labs Limited (PLS) will merge with its Indian counterpart Pine Labs Private Limited as part of the reverse flipping. While the company has received t ...
AstraZeneca to build $1.5 billion cancer drug manufacturing plant in Singapore
AstraZeneca plans to build a $1.5 billion manufacturing facility in Singapore to produce a promising category of cancer-killing drugs called antibody-drug conjugates (ADCs), the Anglo-Swedish ...
Astrazeneca to build huge new cancer drug plant in Singapore
Astrazeneca is investing $1.5bn to build a manufacturing facility in Singapore to produce antibody drug conjugates (ADCs), a next-generation cancer treatment.
AstraZeneca plans to build $1.5 billion manufacturing facility in Singapore
AstraZeneca said on Monday it plans to build a $1.5 billion manufacturing facility in Singapore in an effort to enhance its antibody drug conjugates (ADCs) portfolio. The greenfield facility, which ...
AstraZeneca to build US$1.5 billion cancer drug plant in Singapore, reduce industry’s reliance on China
CEO Pascal Soriot is working to ensure AstraZeneca can independently supply drugs to major markets as the US pushes to reduce the industry’s reliance on China.
Pine Labs receives approval from Singapore court to relocate its base to India
Pine Labs, a leading merchant commerce startup, has secured approval from a Singapore court to merge its local entity with its Indian unit, allowing the firm to transfer all its assets and properties.
AstraZeneca To Build $1.5 Bln Manufacturing Facility In Singapore For Antibody Drug Conjugates
British drug major AstraZeneca Plc. (AZN.L, AZN) announced Monday that it intends to build a $1.5 billion manufacturing facility in ...
Johor-Singapore SEZ to spur trade, labour and investments: Maybank
The initiative could help ease the shortage of talent. Maybank Investment Banking Group expects the proposed Johor-Singapore Special Economic Zone (SEZ) to unlock opportunities and spur the exchange ...
Singapore passes key cybersecurity amendment bill to combat risks
Bill on 7 May, crucial for enhancing Singapore’s cybersecurity framework and digital advancement, said Clyde & Co. in an insight. Currently, the Cybersecurity Act covers Critical Information ...
The Singapore-China ties Lawrence Wong inherits from Lee Hsien Loong
Under Lee, bilateral ties were upgraded through economic initiatives and dialogue platforms - despite occasional political hiccups Lee also highlighted multiculturalism in diplomatic exchanges and ...